Number of the records: 1  

Selective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2(high) Breast Cancer

  1. 1.
    SYSNO ASEP0473778
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleSelective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2(high) Breast Cancer
    Author(s) Rohlenová, Kateřina (BTO-N) ORCID, RID
    Sachaphibulkij, K. (AU)
    Stursa, J. (CZ)
    Bezawork-Geleta, A. (AU)
    Blecha, Jan (BTO-N)
    Endaya, B. (AU)
    Werner, L. (CZ)
    Černý, Jiří (BTO-N) RID, ORCID
    Zobalová, Renata (BTO-N) RID
    Goodwin, J. (AU)
    Špaček, Tomáš (FGU-C) RID, ORCID
    Pesdar, E.A. (AU)
    Yan, B. (AU)
    Nguyen, M.N. (AU)
    Vondrusová, Magdaléna (BTO-N) RID
    Sobol, Margaryta (UMG-J) RID
    Ježek, Petr (FGU-C) RID, ORCID
    Hozák, Pavel (UMG-J) RID, ORCID
    Truksa, Jaroslav (BTO-N) RID, ORCID
    Rohlena, Jakub (BTO-N) RID, ORCID
    Dong, L.F. (AU)
    Neužil, Jiří (BTO-N) RID
    Source TitleAntioxidants & Redox Signaling. - : Mary Ann Liebert - ISSN 1523-0864
    Roč. 26, č. 2 (2017), s. 84-103
    Number of pages20 s.
    Languageeng - English
    CountryUS - United States
    Keywordsmitochondrially targeted tamoxifen ; HER2 ; respirasome
    Subject RIVEB - Genetics ; Molecular Biology
    OECD categoryBiochemistry and molecular biology
    Subject RIV - cooperationInstitute of Physiology - Genetics ; Molecular Biology
    Institute of Molecular Genetics - Genetics ; Molecular Biology
    R&D ProjectsGA16-12719S GA ČR - Czech Science Foundation (CSF)
    GA16-22823S GA ČR - Czech Science Foundation (CSF)
    GA13-28830S GA ČR - Czech Science Foundation (CSF)
    GA16-12816S GA ČR - Czech Science Foundation (CSF)
    TE01020118 GA TA ČR - Technology Agency of the Czech Republic (TA ČR)
    FR-TI3/588 GA MPO - Ministry of Industry and Trade (MPO)
    LQ1604 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    ED1.1.00/02.0109 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportBTO-N - RVO:86652036 ; FGU-C - RVO:67985823 ; UMG-J - RVO:68378050
    UT WOS000391823300003
    EID SCOPUS85008884183
    DOI10.1089/ars.2016.6677
    AnnotationAims: Expression of the HER2 oncogene in breast cancer is associated with resistance to treatment, and Her2 may regulate bioenergetics. Therefore, we investigated whether disruption of the electron transport chain (ETC) is a viable strategy to eliminate Her2(high) disease.
    WorkplaceInstitute of Biotechnology
    ContactMonika Kopřivová, Monika.Koprivova@ibt.cas.cz, Tel.: 325 873 700
    Year of Publishing2018
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.